{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:22:57Z","timestamp":1788906177583,"version":"build-2803163510"},"reference-count":68,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jaip.2025.02.028","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T02:52:09Z","timestamp":1740797529000},"page":"990-999","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Insulin Allergy: The Allergist\u2019s Updated Approach to Evaluation and Management"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4054-2491","authenticated-orcid":false,"given":"Jessica","family":"Oh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn Capellan","family":"Vasquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Alvarez-Arango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana C.","family":"Castells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2025.02.028_bib2","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/dmrr.714","article-title":"Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues","volume":"23","author":"Radermecker","year":"2007","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jaip.2025.02.028_bib3","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1007\/s00125-022-05710-9","article-title":"Insulin allergy: a diagnostic and therapeutic strategy based on a retrospective cohort and a case\u2013control study","volume":"65","author":"Sola-Gazagnes","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/j.jaip.2025.02.028_bib4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1210\/er.2007-0002","article-title":"Immunological responses to exogenous insulin","volume":"28","author":"Fineberg","year":"2007","journal-title":"Endocr Rev"},{"issue":"suppl 9","key":"10.1016\/j.jaip.2025.02.028_bib5","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jaip.2020.08.006","article-title":"Practical guidance for the evaluation and management of drug hypersensitivity: specific drugs","volume":"8","author":"Broyles","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.02.028_bib6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM200301163480320","article-title":"Insulin-injection-site reactions associated with type I latex allergy","volume":"348","author":"Roest","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2025.02.028_bib7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2337\/diacare.19.2.184a","article-title":"Latex allergy in diabetic patients: a call for latex-free insulin tops","volume":"19","author":"MacCracken","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jaip.2025.02.028_bib8","first-page":"e147","article-title":"Rapid desensitization with intravenous insulin in a patient with diabetic ketoacidosis and insulin allergy","volume":"6","author":"Shuster","year":"2020","journal-title":"AACE Clin Case Rep"},{"key":"10.1016\/j.jaip.2025.02.028_bib9","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2337\/diab.39.6.728","article-title":"Persistent cutaneous insulin allergy resulting from high-molecular-weight insulin aggregates","volume":"39","author":"Ratner","year":"1990","journal-title":"Diabetes"},{"key":"10.1016\/j.jaip.2025.02.028_bib10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2025.02.028_bib11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.12788\/j.sder.0058","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: clinical patterns, diagnostic considerations, etiology, and therapeutic management","volume":"33","author":"Mockenhaupt","year":"2014","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaip.2025.02.028_bib12","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1080\/00015550252948149","article-title":"Insulin-induced drug eruptions and reliability of skin tests","volume":"82","author":"Lee","year":"2002","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2025.02.028_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1226231","article-title":"Case report: insulin hypersensitivity in youth with type 1 diabetes","volume":"14","author":"Alkhatib","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jaip.2025.02.028_bib14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.iac.2021.12.004","article-title":"The who, what, where, when, why, and how of drug desensitization","volume":"42","author":"Yang","year":"2022","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2025.02.028_bib15","first-page":"346","article-title":"Rapid desensitization for insulin allergy in type 1 diabetes using an insulin pump: a case report and literature review","volume":"7","author":"Tian","year":"2021","journal-title":"AACE Clin Case Rep"},{"key":"10.1016\/j.jaip.2025.02.028_bib16","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.iac.2017.06.001","article-title":"Subcutaneous injectable drugs hypersensitivity and desensitization: insulin and monoclonal antibodies","volume":"37","author":"Bavbek","year":"2017","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2025.02.028_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11882-022-01052-z","article-title":"Utilizing biologics in drug desensitization","volume":"23","author":"Yang","year":"2023","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2025.02.028_bib18","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1056\/NEJMoa2312382","article-title":"Omalizumab for the treatment of multiple food allergies","volume":"390","author":"Wood","year":"2024","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2025.02.028_bib19","doi-asserted-by":"crossref","DOI":"10.2337\/dc12-0115","article-title":"Successful use of omalizumab in an inadequately controlled type 2 diabetic patient with severe insulin allergy","volume":"35","author":"Cavelti-Weder","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jaip.2025.02.028_bib20","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMc0808282","article-title":"Rituximab and omalizumab in severe, refractory insulin allergy","volume":"360","author":"Yong","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2025.02.028_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13601-018-0223-x","article-title":"Insulin allergy can be successfully managed by a systematic approach","volume":"8","author":"Haastrup","year":"2018","journal-title":"Clin Transl Allergy"},{"issue":"5","key":"10.1016\/j.jaip.2025.02.028_bib22","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/dme.13591","article-title":"Role of omalizumab in insulin hypersensitivity: a case report and review of the literature","volume":"35","author":"Mishra","year":"2018","journal-title":"Diabet Med"},{"key":"10.1016\/j.jaip.2025.02.028_bib23","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.jaci.2007.07.037","article-title":"Omalizumab for drug allergy","volume":"120","author":"Matheu","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.02.028_bib24","first-page":"140","article-title":"Rituximab therapy for insulin allergy in type-1 diabetes mellitus","volume":"10","author":"DeClue","year":"2024","journal-title":"AACE Clin Case Rep"},{"key":"10.1016\/j.jaip.2025.02.028_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/jcpt.12602","article-title":"Rapid decline in insulin antibodies and glutamic acid decarboxylase autoantibodies with ibrutinib therapy of chronic lymphocytic leukaemia","volume":"43","author":"Skrabs","year":"2018","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"10.1016\/j.jaip.2025.02.028_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.844040","article-title":"Insulin allergy to detemir followed by rapid onset of diabetic ketoacidosis: a case report and literature review","volume":"13","author":"Teo","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jaip.2025.02.028_bib27","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.clindermatol.2010.11.009","article-title":"Insulin allergy","volume":"29","author":"Ghazavi","year":"2011","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaip.2025.02.028_bib28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1398-9995.2007.01567.x","article-title":"Insulin allergy: clinical manifestations and management strategies","volume":"63","author":"Heinzerling","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.02.028_bib29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1089\/dia.2020.0438","article-title":"Recurrent diabetic ketoacidosis and extreme insulin resistance due to anti-insulin antibodies: response to immunosuppression and plasma exchange","volume":"23","author":"Ahmed","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jaip.2025.02.028_bib30","first-page":"3658","article-title":"Insulin inhibitors and insulin resistance","volume":"60","author":"Berson","year":"1960","journal-title":"NY State J Med"},{"key":"10.1016\/j.jaip.2025.02.028_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2024.1357901","article-title":"A\u00a0case report and systematic literature review: insulin-induced type III hypersensitivity reaction","volume":"5","author":"Meredith","year":"2024","journal-title":"Front Allergy"},{"key":"10.1016\/j.jaip.2025.02.028_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2019.02.015","article-title":"Harmonization of immunoassays for biomarkers in diabetes mellitus","volume":"39","author":"Horber","year":"2020","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.jaip.2025.02.028_bib33","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2147\/DMSO.S219438","article-title":"Insulin autoimmune syndrome (Hirata disease): a comprehensive review fifty years after its first description","author":"Cappellani","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.jaip.2025.02.028_bib34","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2337\/diacare.9.3.318","article-title":"Use of low-dose continuous corticosteroid infusion to facilitate insulin pump use in local insulin hypersensitivity","volume":"9","author":"Grant","year":"1986","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jaip.2025.02.028_bib35","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.jaip.2024.06.047","article-title":"Delayed skin testing for systemic medications: helpful or not?","volume":"12","author":"Barbaud","year":"2024","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.02.028_bib36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00128071-200708010-00003","article-title":"Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs","volume":"8","author":"Radermecker","year":"2007","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaip.2025.02.028_bib37","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2337\/dc07-1739","article-title":"Human insulin analog\u2013induced lipoatrophy","volume":"31","author":"Lopez","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jaip.2025.02.028_bib38","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.2337\/diacare.19.11.1283","article-title":"Insulin-induced lipoatrophy in type I diabetes: a possible tumor necrosis factor-\u03b1-mediated dedifferentiation of adipocytes","volume":"19","author":"Atlan-Gepner","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jaip.2025.02.028_bib39","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2337\/diacare.29.04.06.dc06-0004","article-title":"Human insulin\u2013induced lipoatrophy: a successful treatment with glucocorticoid","volume":"29","author":"Ramos","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jaip.2025.02.028_bib40","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/pedi.13094","article-title":"Lipoatrophy in children, adolescents and adults with insulin pump treatment: is there a beneficial effect of insulin glulisine?","volume":"21","author":"Kordonouri","year":"2020","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jaip.2025.02.028_bib41","doi-asserted-by":"crossref","first-page":"93","DOI":"10.33176\/AACB-20-00008","article-title":"Clinical and laboratory aspects of insulin autoantibody-mediated glycaemic dysregulation and hyperinsulinaemic hypoglycaemia: insulin autoimmune syndrome and exogenous insulin antibody syndrome","volume":"41","author":"Huynh","year":"2020","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.jaip.2025.02.028_bib42","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.4239\/wjd.v15.i7.1489","article-title":"Association between glucose-lowering drugs and circulating insulin antibodies induced by insulin therapy in patients with type 2 diabetes","volume":"15","author":"Zhang","year":"2024","journal-title":"World J Diabetes"},{"key":"10.1016\/j.jaip.2025.02.028_bib43","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/MED.0000000000000263","article-title":"Type B insulin resistance syndrome","volume":"23","author":"Willard","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.jaip.2025.02.028_bib44","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1210\/clinem\/dgaa911","article-title":"A\u00a0novel type of extreme insulin resistance: nonhypoglycemic insulin autoimmune syndrome","volume":"106","author":"Liu","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"suppl 1","key":"10.1016\/j.jaip.2025.02.028_bib45","first-page":"S200","article-title":"14. Management of diabetes in pregnancy: standards of medical care in diabetes-2021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jaip.2025.02.028_bib46","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.3390\/nu14122444","article-title":"Role of beta cell function and insulin resistance in the development of gestational diabetes mellitus","volume":"14","author":"Ellerbrock","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jaip.2025.02.028_bib47","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3803\/EnM.2015.30.3.402","article-title":"Two cases of allergy to insulin in gestational diabetes","volume":"30","author":"Kim","year":"2015","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/j.jaip.2025.02.028_bib48","first-page":"216","article-title":"Skin rash appearing in a patient with gestational diabetes mellitus on insulin therapy","volume":"10","author":"Tsukagoshi-Yamaguchi","year":"2024","journal-title":"AACE Clin Case Rep"},{"key":"10.1016\/j.jaip.2025.02.028_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1215356","article-title":"Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence","volume":"14","author":"Muller","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jaip.2025.02.028_bib50","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jamainternmed.2023.6663","article-title":"Safety of GLP-1 receptor agonists and other second-line antidiabetics in early pregnancy","volume":"184","author":"Cesta","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"4 part 1","key":"10.1016\/j.jaip.2025.02.028_bib51","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S1262-3636(07)70056-3","article-title":"Allergy to insulin in a woman with gestational diabetes mellitus: transient efficiency of continuous subcutaneous insulin lispro infusion","volume":"29","author":"Durand-Gonzalez","year":"2003","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jaip.2025.02.028_bib52","first-page":"41","article-title":"Allergy to insulin analogs in gestational diabetes","volume":"24","author":"Ghamri","year":"2017","journal-title":"J\u00a0King Abdulaziz Univ"},{"issue":"suppl 1","key":"10.1016\/j.jaip.2025.02.028_bib53","article-title":"6810 successful insulin allergy desensitization to humalog during the second trimester of pregnancy","volume":"8","author":"Nore\u00f1a","year":"2024","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.jaip.2025.02.028_bib55","first-page":"827","article-title":"Desensitization with human (recombinant DNA) insulin","volume":"19","author":"Bodendorfer","year":"1985","journal-title":"Drug Intell Clin Pharm"},{"key":"10.1016\/j.jaip.2025.02.028_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13223-021-00554-1","article-title":"The complexities of insulin allergy: a case and approach","volume":"17","author":"Aberumand","year":"2021","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2025.02.028_bib57","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S1081-1206(10)60645-X","article-title":"Delayed-type hypersensitivity reaction to the meta-cresol component of insulin","volume":"99","author":"Kim","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2025.02.028_bib58","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/cod.13467","article-title":"Allergy to metacresol in a type 2 diabetes patient","volume":"82","author":"Colson","year":"2020","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2025.02.028_bib59","year":"2024"},{"key":"10.1016\/j.jaip.2025.02.028_bib60","series-title":"Danbury, Conn","year":"2014"},{"key":"10.1016\/j.jaip.2025.02.028_bib61","first-page":"239","article-title":"Anaphylaxis to excipients in current clinical practice: evaluation and management","volume":"42","author":"Bruusgaard-Mouritsen","year":"2022","journal-title":"Immunol Allergy Clin"},{"key":"10.1016\/j.jaip.2025.02.028_bib62","first-page":"259","article-title":"Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. Drug allergy: an updated practice parameter","volume":"105","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2025.02.028_bib63","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0140-6736(79)90517-8","article-title":"\"Insulin\" allergy due to zinc","volume":"313","author":"Feinglos","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2025.02.028_bib64","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2337\/diacare.10.6.789","article-title":"Generalized allergy due to zinc and protamine in insulin preparation treated with insulin pump","volume":"10","author":"Gin","year":"1987","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jaip.2025.02.028_bib65","doi-asserted-by":"crossref","first-page":"552","DOI":"10.2337\/diacare.9.5.552b","article-title":"Case of generalized allergy due to zinc and protamine in insulin preparation","volume":"9","author":"Bruni","year":"1986","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jaip.2025.02.028_bib66","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/cod.13529","article-title":"Adverse cutaneous reaction to diabetic glucose sensors and insulin pumps: irritant contact dermatitis or allergic contact dermatitis?","volume":"83","author":"Herman","year":"2020","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2025.02.028_bib67","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/jdv.20089","article-title":"Allergic contact dermatitis and irritant contact dermatitis from medical devices used by patients with insulin-dependent diabetes mellitus","volume":"38","author":"Franca","year":"2024","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2025.02.028_bib68","first-page":"210","article-title":"Insulin allergy: a case report and review of literature","volume":"32","author":"Natali","year":"2016","journal-title":"J\u00a0Pharm Technol"},{"key":"10.1016\/j.jaip.2025.02.028_bib69","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s40257-017-0275-z","article-title":"Cutaneous manifestations of diabetes mellitus: a review","volume":"18","author":"Lima","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaip.2025.02.028_bib70","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/00128071-200304100-00001","article-title":"Skin-related complications of insulin therapy: epidemiology and emerging management strategies","volume":"4","author":"Richardson","year":"2003","journal-title":"Am J Clin Dermatol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825002004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825002004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T23:14:25Z","timestamp":1753226065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219825002004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":68,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2213219825002004"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2025.02.028","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin Allergy: The Allergist\u2019s Updated Approach to Evaluation and Management","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2025.02.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}